{
    "clinical_study": {
        "@rank": "156403", 
        "arm_group": {
            "arm_group_label": "morbidly obese, chronic renal disease", 
            "description": "adult patients (> 18 years) who have stage 4 or 5 chronic renal disease (CrCl < 30 ml/min) who are being considered for possible future kidney transplantation. The study inclusion criteria are an indication for laparoscopic sleeve gastrectomy (BMI > 40 kg/m2, or BMI > 35 with at least one co-morbidity such as hypertension, dyslipidemia or diabetes)"
        }, 
        "biospec_descr": {
            "textblock": "plasma"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "A prospective clinical trial will study the effects of laparoscopic sleeve gastrectomy in\n      the potential renal transplant candidate who is denied acceptance due mainly to the morbid\n      obesity."
        }, 
        "brief_title": "Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate", 
        "completion_date": {
            "#text": "July 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity, Morbid", 
            "Transplant; Failure, Kidney"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity, Morbid", 
                "Renal Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "The remaining factor in determining the effectiveness of bariatric surgery in the transplant\n      population will be to study the effect on the pharmacokinetics of immunosuppressive\n      medication, height, weight, BMI, abdominal circumference, blood pressure, Hba1c , average\n      daily insulin requirements, lipid profile, TSH, 24h urine creatinine clearance and the SF-36\n      Quality of life questionnaire."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult (>18 years)\n\n          -  stage IV and V chronic renal disease (glomerular filtration rate < 30 ml/min,\n\n          -  body mass index (BMI) of greater than 40 kg/m2 or > 35 with at least one co-morbidity\n             such as hypertension, dyslipidemia or diabetes\n\n        Exclusion Criteria:\n\n          -  medically unfit for surgical intervention\n\n          -  previous gastric or intestinal surgery\n\n          -  active gastric disease\n\n          -  pregnancy  or lactation\n\n          -  known intolerance to tacrolimus or mycophenolic acid\n\n          -  awaiting potential multi-organ transplantation\n\n          -  active infection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "morbidly obese, kidney transplant candidate with stage IV or V chronic renal disease"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913392", 
            "org_study_id": "CAGS2012"
        }, 
        "intervention": {
            "arm_group_label": "morbidly obese, chronic renal disease", 
            "description": "laparoscopic sleeve gastrectomy", 
            "intervention_name": "laparoscopic sleeve gastrectomy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 31, 2013", 
        "location": {
            "contact": {
                "email": "lboutin.hmr@ssss.gouv.qc.ca", 
                "last_name": "Lucie Boutin, RN", 
                "phone": "514-252-3400", 
                "phone_ext": "6500"
            }, 
            "contact_backup": {
                "email": "ggagne.hmr@ssss.gouv.qc.ca", 
                "last_name": "Guylaine Gagne, RN", 
                "phone": "514-252-3400", 
                "phone_ext": "4484"
            }, 
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H1T2M4"
                }, 
                "name": "Maisonneuve-Rosemont Hospital"
            }, 
            "investigator": {
                "last_name": "Chan Gabriel, Md", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective, Clinical Study of the Effect of Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, on the Pharmacokinetics of Immunosuppressive Drugs in the Morbidly Obese, Kidney Transplant Candidate", 
        "overall_official": {
            "affiliation": "Maisonneuve-Rosemont Hospital", 
            "last_name": "Gabriel Chan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "changes in the pharmacokinetics of oral immunosuppressive medications due to bariatric surgery, comparing pre-bariatric surgery to 12 months post-operative", 
                "safety_issue": "No", 
                "time_frame": "pre-bariatric surgery and 1 year after surgery"
            }, 
            {
                "measure": "degree of weight loss achieved after bariatric surgery in the chronic renal failure patient.", 
                "safety_issue": "No", 
                "time_frame": "baseline and every 3 months"
            }, 
            {
                "measure": "Evaluate the change in general quality of life score, SF-36", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 1 year after bariatric surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913392"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Maisonneuve-Rosemont Hospital", 
            "investigator_full_name": "Gabriel Chan, Md", 
            "investigator_title": "Transplant  and general surgeon", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "evaluate changes to residual renal function in the pre-dialysis renal transplant candidate", 
                "safety_issue": "No", 
                "time_frame": "at baseline versus month 12 post-bariatric surgery"
            }, 
            {
                "measure": "evaluate the change in the number and dose of medications required to treat co-morbidities including, hypertension, hyperlipidemia and diabetes mellitus", 
                "safety_issue": "No", 
                "time_frame": "baseline and 12 month post-bariatric surgery"
            }, 
            {
                "measure": "the incidence of complications post-bariatric surgery will be evaluated", 
                "safety_issue": "No", 
                "time_frame": "1, 6 and 12 months post-bariatric surgery"
            }
        ], 
        "source": "Maisonneuve-Rosemont Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Canadian surgical research fund", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Astellas Pharma Canada, Inc.", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Maisonneuve-Rosemont Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Observational Model: Case-Crossover, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}